《大行報告》麥格理:對科技板塊保持審慎 降阿裏健康、平安好醫生及京東健康目標價
麥格理髮表報告指,近日內地當局對科技企業出臺不少指導及監管規範,市場關注VIE架構、網絡安全、用戶數據私隱、反壟斷等潛在政策風險,提醒投資者不應只關注事件對估值的影響,更應評估相關因素如何影響盈利表現,及未來業績表現能否達到市場預期水平,從而捕捉良好的投資機會。
但麥格理亦認爲,目前該行業整體盈利尚缺乏明顯的上行空間,盈利預測仍然過高,除騰訊(00700.HK)及阿裏巴巴(09988.HK)外,市場對科技股2022年盈利預測高出了27%,騰訊及阿裏的盈測則高出11%,又指騰訊及阿裏的估值目前正處於歷史水平下限,較爲吸引。
麥格理對科技板塊保持審慎看法,看好阿裏、同程藝龍(00780.HK)及用友軟件(600588.SH);該行維持對美團(03690.HK)和拼多多(PDD.US)的「中性」評級。
該行表示,下調阿裏健康(000241.HK)今明兩年盈利預測約92%及95%,下調目標價由26.8元降至15.4元,評級爲「跑贏大市」;該行降平安好醫生(01833.HK)今明兩年盈利預測調低均47%,目標價降至109元,評級爲「跑贏大市」;麥格理調低京東健康(06618.HK)目標價降至82.1元,下調今年盈測72%,降明年盈測100%,評級爲「跑贏大市」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.